Please provide your email address to receive an email when new articles are posted on . Sotagliflozin increased the number of days alive and out of the hospital compared with placebo among patients ...

Patients with stable ischemic heart disease treated with optimal medical therapy in the ISCHEMIA trial spent more time alive out of the hospital at 2 years when compared with those treated with an ...